synapse-like contact 15 or indirect paracrine communication by secreting soluble mediators, such as IL-6, VEGF and nitric oxide.
11,16
Although telocytes were reported to be involved in multiple autoimmune, inflammatory and fibrotic disorders, 12, 17 their number was decreased and their morphology was disrupted in these conditions. 18 Thus, how telocytes respond and how their secretory profile is changed during stress remains unclear.
TLRs are important sensors in innate and adaptive immunity by recognizing exogenous pathogen-associated molecular patterns (PAMPs) and endogenous molecules. A total of 12 TLR family members were found in mice and 10 were found in humans. 19 TLRs are widely expressed not only on immune cells 20, 21 but also on nonimmune cells, including haematopoietic stem and progenitor cells (HSPCs), 22 endothelial cells, 23 mesenchymal stem cells 24 and fibroblasts. 25 Although TLR activation has been recognized as boosting immune defense, researchers came to realize that TLR ligands could influence the proliferation, apoptosis and differentiation of non-immune cells. TLR2 was expressed on intestinal and mammary epithelial cells. Loss of TLR2 in intestinal epithelial cells led to reduction of tumour formation. Moreover, TLR2 agonists could promote cell colony growth in vitro. 26 Chen and colleagues reported for the first time that TLR3 and TLR4 were more highly expressed on human umbilical cord mesenchymal stem cells (UC-MSCs), activation of which could affect the proliferation and adipogenic differentiation of UC-MSCs. 27 Telocytes were similar to MSCs to some extent. 28 The discovery of TLRs on MSCs led us to explore the effect of TLRs on telocytes, which was still unclear until now.
In our study, we examined the expression of TLRs on cardiac telocytes and evaluated the function of TLRs on regulation of telocytes with TLR ligands. Our data showed that TLR2, which was abundant on telocytes, could significantly enhance the suppressive activity of telocytes on T cell activation.
| MATERIAL S AND ME THODS

| Isolation and culture of cardiac telocytes
Six-week-old male BALB/c mice (Beijing Vital River Laboratory Animal Technology Co., Ltd) were used to harvest hearts, which were placed in 1× PBS supplemented with 1% penicillin and streptomycin (PS). The hearts were minced into 1 mm 3 pieces in a sterile culture dish containing Dulbecco's modified Eagle's medium (DMEM)/F12 (C11330500BT, Gibco; Thermo Fisher Scientific, Inc, China) supplemented with 1% PS. The pieces were washed by centrifugation at 300g for 5 minutes and were resuspended in PBS to remove the blood. An enzymatic digestion medium (collagenase II, Sigma-Aldrich, 2 mg/mL) was added and the mixture was incubated at 37°C on a shaker for 1 hour. 1× PBS was required to terminate digestion. The solution was filtered through a 70 μm nylon mesh (EMD Millipore) and the collected suspension was centrifuged at 300g for 10 minutes. The cells were then seeded into 25 cm 2 culture dishes containing DMEM/F12 supplemented with 10% foetal bovine serum (FBS; 10099-141; Gibco; Thermo Fisher Scientific, Inc) and 1% PS and cultured at 37°C for 1.5 hours to allow fibroblast attachment. The unattached cells (almost telocytes) were replated onto a new dish with the above medium and the medium was replaced 24 hours later. Cells were selected, purified and further amplified for further experiments. Cell cultures were examined using an inverted microscope and photographed at different time-points after seeding.
| Flow cytometry
When purified telocytes had grown to 80% confluence, cells were detached by digestion in 0.25% trypsin/EDTA (Invitrogen, Thermo
Fisher Scientific, Inc) within 1 minute. Then, cells were harvested for flow cytometry. The antibodies were used as follows: PE-anti-CD34, -TLR2, -TLR3, -PD-1; APC-anti-CD3, -CD140a (PDGFR-α);
and Alexa Fluor ® 488 anti-CD8α. All antibodies were purchased from BioLegend. Data were collected on a FACSVerse flow cytometer (BD Biosciences) and analysed using FlowJo software (TreeStar, Inc).
| Immunofluorescent staining
Immunofluorescence staining was performed as described. 29 The primary antibodies (armenian Hamster anti-CD34, rat anti-CD140a)
were purchased from BioLegend. The secondary antibodies (DyLight™ 594 Goat anti-hamster IgG, FITC-Conjugated Goat antiRat IgG) were purchased from Biolegend and ZSGB-Bio respectively.
| TLR activation of telocytes
When telocytes grew to 80% confluence, the supernatant was discarded and fresh medium (5% FBS, Gibco; DMEM/F12) was added into the system. Telocytes were stimulated with the TLR2 agonist Pam3CSK4 (3 μg/mL, Invivogen) or the TLR3 agonist PolyI:C (5 μg/ mL, Invivogen) for 24 hours. Then, the supernatants were collected for further experiments.
| Apoptosis assay
Telocytes treated as above were collected for the apoptosis assay.
An Annexin V-FITC/PI kit (BD Pharmingen) was used to stain cells for 15 minutes protected from light following the instruction. Flow cytometry was applied to detect cell apoptosis immediately. The TUNEL Apoptosis Assay Kit was purchased from Beyotime (Shanghai, China) and performed following the manufacturer's instructions.
| RT-PCR
Total RNA was isolated from telocytes and fibroblasts and realtime qPCR was performed. Primer information is provided in the Supplementary Materials and Methods.
| ELISA
ELISA kits for IL-6, VEGF, TNF-α, MCP-1 (DAKEWE) and iNOS (Wuhan EIAab Science Co., Ltd.) were used to quantify cytokines.
| T cell suppression assay
Supernatants of telocytes were collected after Pam3CSK4 stimulation with or without iNOS inhibitor for 24 hours. Lymphocytes 
| Statistical analysis
All statistical analyses were performed with an unpaired Student's t test. The data are expressed as the mean ± SEM and differences were considered statistically significant when P < 0.05 (*P < 0.05; **P < 0.01; ***P < 0.001).
| RE SULTS
| Identification of cardiac telocytes
To examine the expression of TLRs on telocytes, we first attempted to isolate purified telocytes. As described in the methods, telocytes were purified after a repeated selection process. Telocytes were identified via morphology after primary cell culture at different time-points ( Figure 1A ). Telocytes are characterized by a small cell body (Tc), the presence of extremely long and thin prolongations (telopode, Tps) and a significant moniliform aspect with many dilations along the telopode.
Also, immunofluorescence staining was used to observe the morphology of telocytes. Cardiac telocytes were double positive for CD34/ PDGFR-α with moniliform telopodes ( Figure 1B ). Next, we used anti-CD34/PDGFR-α to identify the immunophenotype of telocytes using flow cytometry analysis. As shown in Figure 1C , cardiac telocytes expressed high levels of the two markers, indicating that the isolated telocytes were highly purified.
| TLR expression of telocytes
The TLR expression of telocytes was analysed using RT-PCR and flow cytometry. Telocytes expressed TLR2, TLR3 and TLR5 at relatively high mRNA levels and TLR1, TLR4, TLR6, TLR7, TLR8 and TLR9 at lower levels ( Figure 2A ). On the contrast, cardiac fibroblasts expressed high levels of TLR2, TLR3 and TLR4 and lower levels of TLR1, TLR5, TLR6, TLR7, TLR8 and TLR9 ( Figure S1 ). These data indicated that cardiac telocytes and fibroblasts had different patterns of TLRs. Then TLR2 and TLR3 expression were confirmed using flow cytometry. As ex- These data suggested that TLR2 and TLR3 might play important roles in regulating telocytes. According to the mRNA and protein expression of TLRs by telocytes, Pam3CSK4 (TLR1&2 ligand) and Poly I:C (TLR3 ligand) were used to stimulate telocytes in the following experiments.
| The effect of TLR activation on telocyte proliferation and apoptosis
Previous study showed that cardiac telocytes were reduced because of higher rates of cell apoptosis under heart failure. 30 To 
(B)
Immunofluorescence staining for CD34 (red) and PDGFR-α (green) with DAPI for nuclei. (C) The expression of PDGFR-α and CD34 on purified telocytes were examined using flow cytometry investigate whether TLR had an effect on cell survival, telocytes
were treated with TLR agonists for 24 hours. PCNA (proliferating cell nuclear antigen) was down-regulated after TLR2 or TLR3 activation ( Figure 3A ). Apoptotic cells were positively stained with Annexin V or double positively stained with Annexin V and PI, whereas dead cells were only PI positive. Pam3CSK4 induced Figure 3B,3) . Moreover, we performed TUNEL staining to confirm our finding. As expected, stimulation of TLR2 or TLR3 could induce obvious apoptosis of telocytes ( Figure 3D ). These data indicated that TLR2 and TLR3 agonists could inhibit telocyte proliferation and promote apoptosis.
| Telocyte secretory factors after TLR ligand stimulation
As some groups described, telocytes could secret many factors, including cytokines, chemokines and extracellular vesicles. TNF-α and MCP-1 were increased after TLR ligand stimulation.
VEGF was down-regulated after TLR3 activation, whereas it was not changed in the Pam3CSK4-treated group when compared with the control group ( Figure 4A ). However, there were some discrepancies at the protein level ( Figure 4B ). These data suggested that TLR2 and TLR3 activation might induce different signalling pathways, resulting in diverse cytokine production. Unexpectedly, we found that telocytes could produce more abundant iNOS via TLR2 activation at the mRNA and protein levels compared with that via TLR3 activation ( Figure 4C,4) , which attracted our attention for further investigation.
| PAm3CSK4-pretreated telocytes suppress T cell activation through iNOS
As we found above, Pam3CSK4 treatment could induce telocytes to produce large amounts of iNOS, which was reported to have immunosuppression ability. Therefore, we posited that telocytes could inhibit T cell activation. We performed co-culture experiments to verify our hypothesis. Telocyte-conditioned medium (TE-CM) from telocytes 
| D ISCUSS I ON
Telocytes, a unique cell type, have gradually attracted our attention in the past 10 years. Previous studies focused on the morphology of telocytes 31, 32 and their role in disease. 18, 33, 34 However, the receptors on telocytes and their functions are still unknown. To our knowledge, this is the first study to demonstrate the expression of Toll-like receptors and their immunoregulatory effects on telocytes.
The results reported herein showed that TLR2 was dominantly expressed on telocytes among the TLR family and that its activation could enhance the immunosuppressive ability of telocytes.
The immunophenotype and receptors of telocytes were still not clear because of their short history. CD34 and PDGFR-α were the most common markers for identifying telocytes in many organs. 29, 35, 36 These markers indicated that telocytes might possess some features similar to stem cells and fibroblasts, although several groups had demonstrated differences. [37] [38] [39] Vimentin and c-kit were used to identify telocytes in the bovine teat sphincter and human lung. presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 recognition. However, whether telocytes express pattern recognition receptors, such as TLRs, has not been clarified thus far. We demonstrated here initially that telocytes expressed high levels of TLR2 and TLR3 compared with other TLRs (Figure 2A2 ), indicating their possible roles in recognizing microorganisms. TLR2 and TLR3 are the first innate immune receptors found in the telocytes.
These findings characterize the immunophenotype of telocytes, indicating that they will be regulated by the immune system. We observed increased cell apoptosis after TLRs activation (Figure 3 ).
iNOS was reported as a driver of apoptosis. 45 Indeed, our result
showed that telocytes could produce a large amount of iNOS.
These data suggested that TLRs induced apoptosis of telocytes via the iNOS pathway. and their concentrations were increased by passaging. We activated telocytes with TLR2 and TLR3 agonists in our research; surprisingly, there was a disparity in cytokine production because of the diverse pathways of activated telocytes, which needed to be further investigated ( Figure 4A,4) . In addition, telocytes contained measurable quantities of microRNAs (eg, let-7e, miR-27b, 126-3p, 130a, 21, 22, etc). 16, 52 These microRNAs played an important role in inflammation, 53, 54 which suggested that telocytes might also participate in immunology. However, we did not focus on microRNAs in our study and how the microRNAs changed after TLR activation is still unknown.
Accumulating evidence has indicated that telocytes might and an apoptotic telocyte with condensed chromatin has been found in the vicinity of a dendritic cell in psoriasis. 56 Although a few studies have reported the function of telocytes, 57, 58 little is known about the relationship between telocytes and other cells.
We found that the level of iNOS was significantly increased after TLR2 activation ( Figure 4C The imbalance of apoptosis-regeneration circle in cardiomyocyte induced by viral or bacterial infections contribute to heart injury.
Telocytes were reported to involve in the regeneration of cardiomyocyte. We used the synthetic mimics of viral or bacterial to stimulate cardiac telocytes and found that activated telocytes were more likely to apoptosis and produce more cytokines. These data suggested that the apoptosis of telocytes might lead to the imbalance of cardiac cell composition, which could be one of the causes of heart disease. On the other hand, activated telocytes could secrete iNOS to avoid T cells over-activation, indicating its role in maintaining cardiac homeostasis.
In conclusion, our present study demonstrated that telocytes expressed high levels of TLR2 and TLR3, the activation of which through ligands could modulate the proliferation, secretome and immunosuppression of telocytes. The findings indicated the potential application of telocytes in clinics to prevent T cell over-activation.
However, further studies should focus on the mechanisms that induce telocyte activation and mediate crosstalk between telocytes and other cells. Overall, our data filled in the gap by demonstrating the immunophenotype of telocytes and their function after TLR activation.
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